Answers are grounded in this paper and cite their sources.
Ac-PSMA-617 TAT showed promising disease control rate, even when all other therapeutic options were exhausted, with low treatment-related toxicities.
No takes yet. Share an insight, caveat, or question.
Yadav et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: